BioCentury
ARTICLE | Clinical News

Oncolym: An agreement with Mills Biopharmaceuticals Inc. (Oklahoma City) will allow TCLN to proceed with its Phase II/III trial within the next month. Mills wil

March 20, 1995 8:00 AM UTC

Techniclone International Corp. (TCLN), Tustin, Calif. Product: Oncolym, a radiolabeled monoclonal antibody Indication: Refractory B cell lymphoma Status: An agreement with Mills Biopharmaceuticals ...